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Abstract
Background: Salvianolic acid B (Sal B) was newly reported to be able to attenuate fibrosis in the animal model.
The aim of the present study was to investigate the effect of the intragastric application of Sal B on the prevention
of epidural fibrosis (EF).
Methods: Forty healthy adult male Wistar rats were divided into four treatment groups (n = 10 per group): (1) 10 mg/kg
Sal B, (2) 30 mg/kg Sal B, (3) 50 mg/kg Sal B and (4) Saline (vehicle treatment, control group). All animals underwent a
laminectomy at the lumbar 1–2 (L 1–2) level. After intragastric treatment, all rats were sacrificed at post-operative week 8.
The extent of the epidural scar, the regeneration of the vasculature and the expression levels of vascular endothelial
growth factor (VEGF) were analysed.
Results: The animals’ recovery was uneventful during the experimental period. The extent of the epidural scar,
the regeneration of the vasculature and the expression levels of VEGF suggested better outcomes in the Sal
B-treated groups. Sal B exerted the ability to prevent the formation of an epidural scar and vascularization at the
laminectomy sites. The effects of Sal B were dose-dependent, with the 50 mg/kg Sal B group showing the best
outcomes compared with the other groups.
Conclusions: Post-operative intragastric application of Sal B can prevent the formation of epidural scarring. Sal B exerted
these effects in a dose-dependent manner, and 50 mg/kg dose was shown to be the best effect in the present study.
The results of this study reveal that Sal B could be a potential therapy for EF and valuable for further research.
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Background
Epidural fibrosis (EF) is widely accepted as one of the
most common factors that contribute to failed back sur-
gery syndrome (FBSS) [1]. FBSS is defined as continuous
low back pain with or without radicular pain after lum-
bar surgery. It was estimated that 25% of post-operative
lumbar patients could suffer FBSS due to EF [2]. EF is
defined as the excessive formation of scar tissue in the epi-
dural space following lumbar laminectomy [3]. As previ-
ously reported, EF is caused by multiple factors including
nerve root tethering, interference of cerebrospinal fluid
flow, destruction of nerve root vascular supply and dural
compression [4].
Considering that another surgery at the same site to
excise the epidural scar could also lead the recurrence of
the scar [5], the current widely accepted modalities for
overcoming EF is to either inhibit or prevent the forma-
tion of excessive scar tissue [6, 7]. Many attempts have
been conducted at both the clinical and experimental
levels [8–10]. However, none of these efforts have re-
sulted in successful clinical application.
Salvianolic acid B (Sal B) is one of the major water-
soluble bioactive component of the traditional Chinese
medical agent, Salvia miltiorrhiza, and has been im-
plemented as a treatment for cardiovascular diseases
[11, 12]. In our previous study, we evaluated the intra-
gastric application of Sal B on the prevention of EF
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in vivo [13]. Based on our results and the latest studies
[13, 14], it was revealed that Sal B is able to exert anti-
fibrotic effect through inhibition of the transforming
growth factor-β (TGF-β) signaling pathway. At the
same time, another studies looking into Sal B’s anti-
inflammatory and anti-fibrotic effects in different rat
models were also recently reported [15–17]. Thus, Sal
B was thought to be potentially beneficial for attenuat-
ing inflammatory and fibrotic process. In our previous
study with a laminectomy rat model, only one dose of
30 mg/kg Sal B was used. In order to further evaluate
the effect of Sal B in a long-term setting and define the
most effective dose and determine the high-dose tox-
icity, the present study was performed.
Methods
Animals
Forty healthy adult male Wistar rats (weight 250 ± 20 g)
were used. The present experiment was approved by the
University Laboratory Animal Care Committee and was
performed in compliance with the European Communi-
ties Council Directive (86/809/EEC) and with the princi-
ples of International Laboratory Animal Care. Animals
were pre-operatively housed in the Qingdao University
animal laboratory for 10 days. The animals randomly di-
vided into four groups based on the different intragastric
treatments (10 rats per group): (1) 10 mg/kg Sal B treat-
ment, (2) 30 mg/kg Sal B treatment, (3) 50 mg/kg Sal B
treatment, and (4) Saline group (vehicle treatment, as
control group). All the rats were euthanized with an an-
aesthesia overdose at post-operative 8 weeks.
Salvianolic acid B administration
Sal B treatment groups: salvianolic acid B (10, 30, and
50 mg/kg diluted in saline) or vehicle (saline) was ad-
ministered intragastrically [13, 17]. Vehicle treatment
group: The same volume of saline was given in the same
way. Varying concentrations of Sal B or vehicle (saline)
was daily administered intragastrically from post-operative
1 day to post-operative 56 days.
Implementation of the laminectomy rat model
The laminectomy rat model was produced as previously
reported [6, 13]. Generally, after general anaesthesia with
10% chloral hydrate (0.3 ml/100 g body weight), all of
the rats were restrained on a temperature pad (setting
temperature 30 °C) in the prone position. All of the rats
were individually marked with ear tags. The rats’ lower
back was shaved and sterilized with a 10% polyvinylpyr-
rolidone/iodine solution. A midline incision was made
from lumbar 1 to lumbar 2 (L1 to L2). After removing
the paraspinal musculature, the L1–L2 laminectomy was
performed. Attention was paid to avoid traumatizing the
dura and the nerve roots. After adequate haemostasis,
the incision was surgically closed in layers.
EF macroscopic evaluation
Eight weeks after the surgery, a macroscopic evaluation
was conducted. All groups were evaluated based on the
Rydell classification under the double-blind principle
(Table 1) [7, 10]. Generally, while the rats were under
general anaesthesia, the surgical incision was carefully
reopened. The state of the epidural scar adhesion was
evaluated with the help of trained assistants.
Histological analysis
At post-operative week 8, a histological analysis was per-
formed. Five rats from each group were randomly se-
lected and euthanized. The entire L1 vertebral column,
including the muscle and scar tissue, was collected and
fixed in a 10% phosphate-buffered formaldehyde solu-
tion. After dehydration and decalcification with a Cal-Ex
II solution, the samples were placed in paraffin, and 5-
μm axial sections of the surgery site were made. The
sections were subjected to immunohistochemistry and
stained with haematoxylin and eosin (H&E). The epi-
dural adhesion status and any vessel regeneration were
detected via H&E staining under a light microscope. To
quantify the fibroblast numbers, immunohistochemistry
with a vimentin antibody (AB92547, 1:400, Abcam,
USA) was performed, and the intensity was calculated.
Western blot
As previously reported, the expressional level of vascular
endothelial growth factor (VEGF) was decreased after
treatment with Sal B [13]. To determine whether the Sal
B-induced changes in the VEGF levels were dose-
dependent, Western blot targeting VEGF was performed
at post-operative week 8 in the present study. Generally,
five rats from each group were randomly selected and eu-
thanized. The epidural scars were collected from the
surgical sites. Then, RIPA lysis buffer was added to lyse
and homogenize the samples. Equivalent protein amounts
(80 μg total protein) were pre-stained with a marker
(#SM0671, Thermo Fisher Scientific) in a buffer contain-
ing 192 mM glycine, 0.1% sodium dodecyl sulfate (SDS)
and 24.8 mM Tris. SDS-polyacrylamide gels (10%) were
run at 80 V for 30 min and 120 V for 2 h to resolve the
Table 1 Rydell classification
Grade 0 Epidural scar tissue was not adherent to the dura mater.
Grade 1 Epidural scar tissue was adherent to the dura mater,
but easily dissected.
Grade 2 Epidural scar tissue was adherent to the dura mater and
difficultly dissected without disrupting the dura matter.
Grade 3 Epidural scar tissue was firmly adherent to the dura mater
and could not be dissected.
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proteins. After the precipitated proteins were separated,
they were transferred to PVDF membranes (LC2005,
Thermo Fisher Scientific) using the following transfer buf-
fer: 10% methanol, 192 mM glycine and 24.8 mM Tris.
Phosphate-buffered saline (PBS) containing 5% non-fat
milk was used to block the membranes for 2 h at room
temperature. The membranes were incubated with anti-
VEGF rabbit polyclonal antibody (Santa Cruz Biotechnol-
ogy, 1:1000) and anti-β-actin mouse monoclonal antibody
(Santa Cruz Biotechnology, 1:10,000) overnight at 4 °C.
To wash off the redundant antibody, the membranes were
repeatedly rinsed in TBS four times. Then, the membranes
were incubated in peroxidase anti-rabbit IgG (Santa Cruz
Biotechnology, 1:10,000) and peroxidase anti-mouse IgG
(Santa Cruz Biotechnology, 1:10,000) for 1.5 h at 4 °C.
After four washes in TBST, the membranes were imaged
using a Bio-Rad ChemiDoc XRS+ by detecting enhanced
chemiluminescence. Film autoradiograms were exposed
from 5 to 15 min.
Statistical analysis
The statistical analysis was performed with the SPSS
16.0 statistical package (SPSS Inc., Chicago, IL, USA).
The data are expressed as the mean ± standard devi-
ation values. The single factor analysis of variance
(ANOVA) and q test were applied to evaluate five inde-
pendent samples. Statistical significance was assumed
at p < 0.05.
Results
Epidural scar adhesion
During the whole experimental period, none of the rats
showed any signs of complications such as neurological
deficits, disturbance of wound healing or wound infection.
In both the 30 mg/kg Sal B and 50 mg/kg Sal B
groups, soft or weak fibrous adhesions were observed.
However, in the 10 mg/kg Sal B and control groups, se-
vere epidural adhesions were observed. Forced dissection
of the epidural scar tissue would lead to serious bleeding
and increase the risk of either nerve root injury or dis-
ruption of the dura mater. The grades of the epidural
adhesions in the rats were determined based on the
Rydell standards (Table 2).
Histological analysis
The status of the epidural scar adhesions is further
shown in Fig. 1. In the laminectomy sites of the 30 mg/
kg Sal B and 50 mg/kg Sal B groups, minimal adhesion
and loose scar tissues were observed (Fig. 1b, c). How-
ever, regarding the laminectomy sites of the 10 mg/kg
Sal B and control groups, extensive adhesion and the
pronounced scar tissues were observed (Fig. 1a, d).
Effect of Sal B on fibroblasts proliferation
As shown in Fig. 2, the fibroblast counts suggested that
compared with the control group (704.22 ± 72.38,
Fig. 2d, e), both the 30 mg/kg Sal B group (489.77 ± 87.61,
p < 0.05, Fig. 2b, e) and 50 mg/kg Sal B group (352.39 ±
89.35, p < 0.05, Fig. 2c, e) showed significant decrease in
the number of fibroblasts at the wound site. At the same
time, compared with the control group, the 10 mg/kg Sal
B group (670.15 ± 81.29, p > 0.05, Fig. 2a, e) showed no
significant change.
Effect of Sal B on vascular regeneration
As shown in Fig. 3, the number of blood vessels in the epi-
dural scar tissue suggested that compared with the control
group (10.23 ± 2.55, Fig. 2d, e), all of the Sal B treatment
groups showed significant differences as follows: 10 mg/kg
Sal B group (8.15 ± 2.76, p < 0.05, Fig. 3a, e), 30 mg/kg Sal
B group (6.48 ± 2.81, p < 0.05, Fig. 3b, e) and 50 mg/kg Sal
B group (6.13 ± 2.45, p < 0.05, Fig. 3c, e).
In accordance with the aforementioned phenomenon
observed based on H&E staining, Western blot targeting
VEGF suggested the same trend as the H&E results. As
shown in Fig. 4, compared with the control group, the ex-
pression levels of VEGF were significantly decreased in all
of the Sal B treating groups. The effect of Sal B on inhibit-
ing VEGF expressions showed the dose-dependent man-
ner. Compared with other groups, 50 mg/kg Sal B had the
most inhibiting effect on VEGF expression.
Discussion
Globally, spinal surgery is annually performed in over
one million patients [18]. EF is thought to be caused by
spinal surgery and was first reported in 1948 [19]. It was
reported that EF is the causative factor of pain in up to
36% of patients with failed back surgery syndrome [20].
Therefore, many researchers and surgeons have been
working to overcome EF since it was first reported [6–10].
However, the underlying pathogenic mechanism of EF is
still unclear, and EF is still one of most challenging prob-
lems after spinal surgery. One of the accepted treatment
modalities for EF is the prevention or reduction of epi-
dural scar formation [4, 21–23].
In previous studies, vascular regeneration was reported
to be one of the most important mechanisms during
wound healing [13, 24]. A series of growth factors and
Table 2 Rydell classification evaluation. The number of animals
matching the various classification criteria was given
Group Grade
0 1 2 3
Sal B (10 mg/kg, n = 10) 0 0 2 8
Sal B (30 mg/kg, n = 10) 6 3 1 0
Sal B (50 mg/kg, n = 10) 8 2 0 0
Control (saline, n = 10) 0 0 0 10
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Fig. 1 The status of epidural scar formation and epidural adhesion in the four groups. In the laminectomy sites of the 10 mg/kg Sal B and
control groups, extensive adhesion and the pronounced scar tissues were observed (a, d). As to the laminectomy sites of the 30 mg/kg Sal B and
50 mg/kg Sal B groups, minimal adhesion and loose scar tissues were observed (b, c). SC spinal cord, D dura, ES epidural scar
Fig. 2 Detection of vimentin via immunohistochemistry and of the number of fibroblasts present in the epidural scar tissue from the four groups:
10 mg/kg Sal B group (a), 30 mg/kg Sal B group (b), 50 mg/kg Sal B group (c) and control group (d). Quantitative analysis was conducted based
on positive cell counting, compared with the control group; all Sal B treating groups showed significant decrease (*p < 0.05 compared to the
control group, **p < 0.05 compared to the control group, ***p < 0.05 compared to the control group) on fibroblasts proliferation (e). Values are
presented as mean ± standard error of the mean
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modulators were thought to be involved in regulating
vascular regeneration. VEGF, as one of the critical fac-
tors of angiogenesis, has been reported to promote this
process through regulating endothelial cell proliferation
[13]. It was suggested that the neutralizing VEGF could
reduce the proliferation of fibroblasts and decrease the re-
generation of blood vessels, while the activating VEGF
would result in the increased growth of fibroblasts and the
neovasculature [25]. Thus, VEGF was selected as the main
indicator in the present study. Our current results sug-
gested the antagonistic effect of Sal B on the expression
levels of VEGF in epidural scars. We hypothesized that
one of the potential mechanisms of Sal B on curtailing EF
was the antagonistic effect of Sal B on VEGF expression.
In our previous research, the results suggested the be-
neficial effects of Sal B on preventing EF with a dose of
30 mg/kg during the first four post-operative weeks. In the
present study, we used three different doses for 8 weeks
after the procedure to further evaluate Sal B’s safety and ef-
fectiveness. The present study suggested that a dose of
50 mg/kg Sal B resulted in the lowest levels of VEGF ex-
pression in the epidural scar and the lowest adhesion, and
none of the animals died or showed any sign of complica-
tions until they were euthanized.
The latest studies in different fields have suggested the
anti-fibrotic activity of Sal B in multiple organ systems such
as pulmonary fibrosis, hepatic fibrosis and oral submucous
fibrosis [14–17, 26–28]. These studies revealed the ability
of Sal B to prevent fibrotic changes both in vitro and
in vivo. It was reported that Sal B could prevent the fibrotic
changes by inhibiting fibroblast proliferation, collagen
deposition and alpha-smooth muscle actin expression [27].
Fig. 3 The status of the vasculature and the number of vessels identified in the epidural scar tissues from the four groups: 10 mg/kg Sal B group
(a), 30 mg/kg Sal B group (b), 50 mg/kg Sal B group (c) and control group (d). Vessel counting quantitative analysis was conducted, compared
with the control group; all Sal B treating groups showed significant decrease (*p < 0.05 compared to the control group, **p < 0.05 compared to
the control group, ***p < 0.05 compared to the control group) on vessel formation (e). Values are presented as mean ± standard error of the mean
Fig. 4 Effect of Sal B on VEGF expression in the epidural scar tissue. The expression levels of VEGF and β-actin in the epidural scar tissue from the
four groups (a). The quantitative analysis was performed based on the greyscale value of straps. Compared with the control group, Sal B treating
groups showed the significant decrease (*p < 0.05 compared to the control group, **p < 0.05 compared to the control group, ***p < 0.05 compared to
the control group) on VEGF expression (b). Values are presented as mean ± standard error of the mean
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In the present study, the post-operative intragastric ad-
ministration of Sal B was employed. Compared with the
intraperitoneal injection and local administration, intra-
gastric administration has the advantages as follows: in-
tragastric administration is able to keep Sal B blood
concentration and attenuate the injury caused by the injec-
tion in a long-term setting and intragastric administration
can accurately control the administration dosage. More
studies looking into the optimal Sal B administration
should be performed in future. At the same time, in the
present study, no complications were observed. Though
our results suggested the effects of Sal B on inhibiting the
fibroblasts proliferation and blood vessel infiltration, no
disturbance of wound healing or wound infection was ob-
served. Considering the dose of 50 mg/kg is the highest
concentration employed in the present research, more
research should be performed to determine the optimal
concentration for Sal B on treating EF in future.
Conclusions
Post-operative intragastric administration of Sal B can
prevent the formation of epidural scars. The effects of
Sal B were dose-dependent, and a 50 mg/kg dose was
suggested as the best effect in the present study. This
study revealed that Sal B could be a potential therapy for
EF and is worth perusing with further research.
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